Ayman Rabayah
☆    

Jordan,
2020-04-08 11:23
(377 d 10:42 ago)

Posting: # 21318
Views: 846
 

 Tegaserod analytical method [Regulatives / Guidelines]

Hello colleagues
I hope you are in good health and conditions, and wish the the COVID-19 crisis come to end in all countries.
kindly we are developing an analytical method for Tegaserod in human plasma, if you have an experience with this product (6 mg dose), is the metabolite M29 need to be included to be detected and measured, and if an LLOQ of 50 pg/ml will be enough?

looking to hear your advises
Thank you
Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 10 (0 registered, 10 guests [including 1 identified bots]).
Forum time: Tuesday 22:06 CEST (Europe/Vienna)

We have to remember that what we observe is not nature herself,
but nature exposed to our method of questioning.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5